0001104659-20-128060.txt : 20201120 0001104659-20-128060.hdr.sgml : 20201120 20201120173615 ACCESSION NUMBER: 0001104659-20-128060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201120 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patient Square Capital LLC CENTRAL INDEX KEY: 0001827614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39597 FILM NUMBER: 201333607 BUSINESS ADDRESS: STREET 1: 8240 MCDANIEL ROAD CITY: FORT WORTH STATE: TX ZIP: 76126 BUSINESS PHONE: 212-446-4600 MAIL ADDRESS: STREET 1: 8240 MCDANIEL ROAD CITY: FORT WORTH STATE: TX ZIP: 76126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Montes Archimedes Acquisition Corp CENTRAL INDEX KEY: 0001819263 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 724 OAK GROVE, SUITE 130 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 212-446-4600 MAIL ADDRESS: STREET 1: 724 OAK GROVE, SUITE 130 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 a4.xml 4 X0306 4 2020-11-20 0 0001819263 Montes Archimedes Acquisition Corp MAAC 0001827614 Patient Square Capital LLC 724 OAK GROVE, SUITE 130 MENLO PARK CA 94025 0 0 1 0 Class B common stock 2020-11-20 4 J 0 1232044 D Class A common stock 1232044 10167956 D This Form 4 reflects the automatic surrender to the issuer of 1,285,637 of the issuer's shares of Class B common stock, par value $0.0001 per share, for no consideration by the reporting person pursuant to contractual arrangements with the issuer, triggered by the expiration of the option of the underwriter of the issuer's initial public offering to purchase additional units. As described in the issuer's registration statement on Form S-1 (File No. 333-248802) under the heading "Description of Securities-Founder Shares", the shares of Class B common stock, par value $0.0001, will automatically convert into shares of Class A common stock, par value $0.0001, of the issuer at the time of the issuer's initial partnering transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. This Form 3 is being filed by Patient Square Capital LLC, sponsor of the issuer ("Sponsor"). Sponsor is controlled by James C. Momtazee. Patient Square Capital LLC, By: /s/ James C. Momtazee, Chief Executive Officer 2020-11-20